Can Hormone Therapy Influence Dementia Risk? New Study Sparks Debate
Menopause is a natural phase in a woman's life, yet its symptoms—hot flashes, mood swings, sleep disturbances, and night sweats—can be anything but comfortable. Hormone Replacement Therapy (HRT) has long been a go-to solution, offering relief by replenishing hormones like estrogen, progesterone, and sometimes testosterone. But here's where it gets controversial: what does HRT really mean for dementia risk? A groundbreaking study published in The Lancet Healthy Longevity dives into this question, and the findings might surprise you.
No Clear Link Found—But Questions Remain
Researchers from the UK, Ireland, Switzerland, Australia, and China analyzed data from over one million women across 10 studies. Their goal? To determine whether HRT affects the risk of mild cognitive impairment (MCI) or dementia in both pre and post-menopausal women. The results? No significant association between HRT and these cognitive conditions. Even factors like the timing, duration, or type of HRT used didn’t seem to make a difference. This aligns with current clinical guidance, which recommends prescribing HRT based on its proven benefits—like symptom relief—rather than as a dementia prevention tool.
But this is the part most people miss: while the study suggests HRT doesn’t increase or decrease dementia risk, it doesn’t close the door on the debate entirely. Lead author Melissa Melville, a PhD student at UCL, emphasizes the urgent need to understand why dementia disproportionately affects women globally. With two-thirds of the 982,000 people living with dementia in the UK being women, the stakes are high. Melville notes, “There’s a pressing need to identify ways to reduce women’s risk of dementia.”
The Debate Rages On
Despite the study’s findings, not everyone is convinced. Menopause specialist Louise Newson argues it’s “impossible to state from this research that HRT does not either increase or reduce dementia risk.” She highlights the role of hormones like progesterone, estradiol, and testosterone in brain health, pointing out that modern HRT uses hormones identical to those naturally produced by the body. Newson believes HRT’s benefits—improved memory, reduced risk of osteoporosis and heart disease—outweigh potential risks.
What’s Next?
The World Health Organization (WHO) currently offers no guidance on HRT and cognitive outcomes, leaving clinicians and policymakers in a bind. Professor Aimee Spector, also from UCL, hopes this study will inform WHO’s upcoming 2026 guidelines on cognitive decline and dementia. Yet, she acknowledges the need for more high-quality, long-term research to fully understand HRT’s impact.
Your Turn: What Do You Think?
Does this study settle the debate, or is there more to uncover? Should women and their doctors feel reassured about HRT’s role in dementia risk? Share your thoughts in the comments—we’d love to hear your perspective!
